Precision Oncology Market Size, Share & Trends Analysis Report By Product Type (Diagnostics, Therapeutics), By Cancer Type (Breast Cancer, Cervical Cancer, Prostate Cancer, Lung Cancer), By End-use (Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, and Healthcare Data Companies), By Region, And Segment Forecasts, 2023-2031

Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global Precision Oncology Market Snapshot Chapter 4. Global Precision Oncology Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Drivers 4.3. Challenges 4.4. Trends 4.5. Investment and Funding Analysis 4.6. Industry Analysis – Porter's Five Forces Analysis 4.7. Competitive Landscape & Market Share Analysis 4.8. Impact of Covid-19 Analysis Chapter 5. Market Segmentation 1: by Ecosystem Estimates & Trend Analysis 5.1. by Ecosystem & Market Share, 2019 & 2031 5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Ecosystem: 5.2.1. Precision Therapeutics 5.2.1.1. Clinical Trials 5.2.1.2. Biomarker Testing 5.2.1.3. Drug Discovery and Research 5.2.1.4. Gene Therapy 5.2.1.5. Cell Therapy 5.2.2. Applied Sciences 5.2.2.1. Genomics 5.2.2.1.1. Polymerase Chain Reaction (PCR) 5.2.2.1.2. Precision Medicine Next-Generation Sequencing 5.2.2.1.3. Genome Editing 5.2.2.1.4. Other Technologies 5.2.2.2. Pharmacogenomics 5.2.2.3. Other Applied Sciences 5.2.3. Digital Health and Information Technology 5.2.3.1. Clinical Decision Support System (CDSS) 5.2.3.2. Big Data Analytics 5.2.3.3. IT Infrastructure 5.2.3.4. Genomics Informatics 5.2.3.5. In-Silico Informatics 5.2.3.6. Mobile Health 5.2.4. Precision Diagnostics 5.2.4.1. Molecular Diagnostics (MDx) 5.2.4.2. Medical Imaging Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis 6.1. by Application & Market Share, 2019 & 2031 6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application: 6.2.1. Solid Tumor 6.2.1.1. Breast Cancer 6.2.1.2. Lung Cancer 6.2.1.3. Colorectal Cancer 6.2.1.4. Prostate Cancer 6.2.1.5. Cervical Cancer 6.2.1.6. Other Cancer 6.2.2. Hematological Malignancies (HMs) 6.2.2.1. Leukemia 6.2.2.2. Lymphoma 6.2.2.3. Myeloma or Multiple Myeloma (MM) 6.2.2.4. Other Hematological Malignancies Chapter 7. Precision Oncology Market Segmentation 4: Regional Estimates & Trend Analysis 7.1. North America 7.1.1. North America Precision Oncology Market Revenue (US$ Million) Estimates and Forecasts by Ecosystem, 2023-2031 7.1.2. North America Precision Oncology Market Revenue (US$ Million) Estimates and Forecasts by Application, 2023-2031 7.1.3. North America Precision Oncology Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031 7.2. Europe 7.2.1. Europe Precision Oncology Market Revenue (US$ Million) Estimates and Forecasts by Ecosystem, 2023-2031 7.2.2. Europe Precision Oncology Market Revenue (US$ Million) Estimates and Forecasts by Application, 2023-2031 7.2.3. Europe Precision Oncology Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031 7.3. Asia Pacific 7.3.1. Asia Pacific Precision Oncology Market Revenue (US$ Million) Estimates and Forecasts by Ecosystem, 2023-2031 7.3.2. Asia Pacific Precision Oncology Market Revenue (US$ Million) Estimates and Forecasts by Application, 2023-2031 7.3.3. Asia Pacific Precision Oncology Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031 7.4. Latin America 7.4.1. Latin America Precision Oncology Market Revenue (US$ Million) Estimates and Forecasts by Ecosystem, 2023-2031 7.4.2. Latin America Precision Oncology Market Revenue (US$ Million) Estimates and Forecasts by Application, 2023-2031 7.4.3. Latin America Precision Oncology Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031 7.5. Middle East & Africa 7.5.1. Middle East & Africa Precision Oncology Market Revenue (US$ Million) Estimates and Forecasts by Ecosystem, 2023-2031 7.5.2. Middle East & Africa Precision Oncology Market Revenue (US$ Million) Estimates and Forecasts by Application, 2023-2031 7.5.3. Middle East & Africa Precision Oncology Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031 Chapter 8. Competitive Landscape 8.1. Major Mergers and Acquisitions/Strategic Alliances 8.2. Company Profiles 8.2.1. Abbott Laboratories 8.2.2. Acrivon Therapeutics 8.2.3. Agilent Technologies, Inc. 8.2.4. Almac Group Ltd. 8.2.5. AstraZeneca 8.2.6. ASURAGEN, INC. 8.2.7. BGI Group 8.2.8. Bio-Rad Laboratories, Inc. 8.2.9. Bioserve 8.2.10. Bristol-Myers Squibb 8.2.11. Eli Lilly 8.2.12. Exact Sciences Corporation 8.2.13. F Hoffmann-La Roche AG 8.2.14. Gilead Sciences, Inc. 8.2.15. Illumina, Inc. 8.2.16. Invitae Corporation 8.2.17. Laboratory Corporation Of America Holding 8.2.18. MDxHealth 8.2.19. Myriad Genetics, Inc. 8.2.20. Novartis AG 8.2.21. OPKO Health, Inc. 8.2.22. Pacific Biosciences of California, Inc. 8.2.23. PerkinElmer Inc. 8.2.24. Qiagen N.V. 8.2.25. Quest Diagnostics Incorporated 8.2.26. Rain Oncology Inc. 8.2.27. Relay Therapeutics 8.2.28. Strata Oncology, Inc. 8.2.29. Thermo Fisher Scientific Inc. 8.2.30. Variantyx, Inc. 8.2.31. Xilis, Inc. 8.2.32. Other Prominent Players